Amphastar Pharma (AMPH) Swings to Q3 Loss

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.07), versus $0.05 reported last year. Revenue for the quarter came in at $59.71 million, versus $59.32 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance